Novartis tries again in Parkinson’s

Novartis, which already has experience with RNA interference therapies, is now turning to this modality as a potential way to treat Parkinson's disease. The pharmaceutical giant is licensing rights to an Arrowhead Pharmaceuticals RNAi therapy designed to inhibit production of alpha synuclein, a protein associated with Parkinson's progression.

Editor's Pick

Top Story Novartis Tries Again in Parkinson's, Putting Up $200M for Arrowhead's RNAi Therapy Novartis, which already has experience with RNA interference therapies, is now turning to this modality as a potential way to treat Parkinson's disease. The pharmaceutical giant is licensing rights to an Arrowhead Pharmaceuticals RNAi therapy designed to inhibit production of alpha synuclein, a protein associated with Parkinson's progression. Sponsored Discover how Mayo Clinic Platform_Solutions Studio can accelerate the commercialization of your digital health solution. Presented by Mayo Clinic Platform_Solutions Studio Whether you're ready to build, validate, or deploy your AI solution into clinical workflows, Solutions Studio offers comprehensive technical and business support tailored to your needs. Learn more We Want Your Feedback Your voice helps shape the stories, insights, and events we deliver. Take just a few minutes to complete our short, anonymous audience survey and let us know what you enjoy and what you'd like to see more of. As a thank you, you'll be entered for a chance to win a $250 Amazon gift card. Take the Survey

Featured News

Beyond the Hospital Walls: Thriving in Value-Based Care [Sponsored] Steve Holt, Vice President of Government Affairs with PointClickCare, discussed what hospitals and ACOs need to succeed with alternative payment model programs such as AHEAD, TEAM, and ACO REACH CMS: ACOs in Shared Savings Program Saved Medicare $2.4B in 2024 Out of the 476 ACOs that participated in the Medicare Shared Savings Program in 2024, 75% earned $4.1 billion in performance payments, CMS reported. Pharma Is Reclaiming Control Over Patient Experience. What Does It Mean For The Hub Model? AI can now flag where patients are getting stuck — from enrollment delays to dropped calls — while also enabling new, compliant ways to analyze these interactions at scale. But surfacing the issue is just the first step.  My Mold Illness Nearly Broke Me — Let's Ensure Others Get the Care They Deserve Symptoms often get labeled as anxiety, chronic fatigue, early neurodegeneration, IBS, or fibromyalgia. How to prevent the root cause — mold exposure — from going unrecognized.

Video   California's efforts to rein in PBMs On Debunked, Paul Markovich, president and CEO of Ascendiun, discussed a proposed California bill that would delink PBM compensation from drug list prices. He cited a recent Health Affairs study that found the change could generate nearly $100 billion in savings.

Sponsored The Definitive Guide to Medical Billing Outsourcing: 5 Top Companies Presented by Global Healthcare Resource In today's healthcare landscape, your choice of medical billing partner directly impacts your bottom line. What are the best medical billing outsourcing companies, and which one is right for you? Learn More.

Resources

sponsored 5 Top-Rated Electronic Medical Records Software for SMBs This report can help small and midsize businesses compare the five top-rated EMR software solutions. Read More

MedCity News • PO Box 901 • New York, NY unsubscribe